VIASPACE (VSPC) 10-K 14 Apr 16 2015 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2015	Apr. 14, 2016	Jun. 30, 2015
Document And Entity Information
Entity Registrant Name	VIASPACE Inc.
Entity Central Index Key	1,270,200
Document Type	10-K
Document Period End Date	Dec. 31, 2015
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$ 3,335,804
Entity Common Stock, Shares Outstanding		2,256,684,676
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2,015

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2015	Dec. 31, 2014
CURRENT ASSETS
Cash and equivalents	$ 10,000	$ 13,000
Accounts receivable	41,000	0
Prepaid expenses	69,000	250,000
TOTAL CURRENT ASSETS	120,000	263,000
FIXED ASSETS, NET	0	0
OTHER ASSETS:
Investment in Almaden Energy Group	40,000	0
Other assets	2,000	1,000
TOTAL OTHER ASSETS	42,000	1,000
TOTAL ASSETS	162,000	264,000
CURRENT LIABILITIES
Accounts payable	93,000	58,000
Accrued expenses	73,000	65,000
Unearned revenue	47,000	65,000
Related party payables	656,000	640,000
TOTAL CURRENT LIABILITIES	$ 869,000	$ 828,000
COMMITMENTS AND CONTINGENCIES (Note 10)
SHAREHOLDERS' DEFICIT:
Preferred stock, $0.0001 par value in 2015 and $0.001 in 2014, 10,000,000 shares authorized, one share of Series A preferred stock issued and outstanding in 2015 and 2014	$ 0	$ 0
Common stock, $0.0001 par value in 2015 and $0.001 in 2014, 3,900,000,000 shares authorized, 1,995,451,343 and 1,562,431,607 shares issued and outstanding in 2015 and 2014, respectively	200,000	1,562,000
Additional paid in capital	51,340,000	48,115,000
Accumulated deficit	(52,247,000)	(50,241,000)
Total shareholders' deficit	(707,000)	(564,000)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$ 162,000	$ 264,000

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Preferred stock par value	$ .0001	$ 0.001
Preferred stock shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	1	1
Preferred stock, shares outstanding	1	1
Common stock par value	$ .0001	$ 0.001
Common stock shares authorized	3,900,000,000	1,800,000,000
Common stock, shares issued	1,995,451,343	1,562,431,607
Common stock, shares outstanding	1,995,451,343	1,562,431,607

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Income Statement [Abstract]
REVENUES	$ 188,000	$ 153,000
COST OF REVENUES	87,000	46,000
GROSS PROFIT	101,000	107,000
OPERATING EXPENSES
Operations	61,000	57,000
Selling, general and administrative	1,376,000	669,000
Total operating expenses	1,437,000	726,000
LOSS FROM OPERATIONS	(1,336,000)	(619,000)
OTHER INCOME (EXPENSE)
Interest expense	(710,000)	(138,000)
Other expense	(44,000)	0
Other income	84,000	5,000
Total other expense	(670,000)	(133,000)
LOSS BEFORE INCOME TAXES	(2,006,000)	(752,000)
Income taxes	0	0
NET LOSS	$ (2,006,000)	$ (752,000)
LOSS PER SHARE OF COMMON STOCK - Basic and diluted	$ 0	$ 0	[1]
WEIGHTED AVERAGE SHARES OUTSTANDING - Basic and diluted	1,704,277,945	1,520,187,700
[1]	Less than $0.01 per common share

CONSOLIDATED STATEMENTS OF SHAR

CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (DEFICIT) - USD ($)	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Total
Beginning balance, shares at Dec. 31, 2013	1,489,332,999
Beginning balance, value at Dec. 31, 2013	$ 1,489,000	$ 47,432,000	$ (49,489,000)	$ (568,000)
Shares issued for consulting services, shares	30,273,846
Shares issued for consulting services, value	$ 30,000	263,000		293,000
Beneficial conversion feature of convertible debt		137,000		137,000
Stock issued upon conversion of note payable, shares	42,824,762
Stock issued upon conversion of note payable, value	$ 43,000	222,000		265,000
Non cash compensation related to stock options		61,000		61,000
Net loss			(752,000)	(752,000)
Ending balance, shares at Dec. 31, 2014	1,562,431,607
Ending balance, value at Dec. 31, 2014	$ 1,562,000	48,115,000	(50,241,000)	(564,000)
Shares issued for consulting services, shares	10,991,009
Shares issued for consulting services, value	$ 11,000	83,000		94,000
Beneficial conversion feature of convertible debt		709,000		709,000
Stock issued upon conversion of note payable, shares	321,767,290
Stock issued upon conversion of note payable, value	$ 202,000	186,000		388,000
Stock issued upon purchase of common shares, shares	80,975,723
Stock issued upon purchase of common shares, value	$ 82,000	118,000		200,000
Stock issued to officer at discount, shares	18,285,714
Stock issued to officer at discount, value	$ 6,000	33,000		39,000
Non cash compensation related to stock options		433,000		433,000
Par value adjustment	$ (1,663,000)	1,663,000		0
Net loss			(2,006,000)	(2,006,000)
Ending balance, shares at Dec. 31, 2015	1,995,451,343
Ending balance, value at Dec. 31, 2015	$ 200,000	$ 51,310,000	$ (52,247,000)	$ (707,000)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (2,006,000)	$ (752,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock option and stock compensation	463,000	61,000
Stock issued for consulting expense	272,000	293,000
Amortization of debt discount	709,000	137,000
Gain on minority investment in Almaden Energy Group	(40,000)	0
Decrease (increase) in:
Accounts receivable	(41,000)	0
Prepaid expenses	103,000	69,000
Accounts payable	35,000	26,000
Accrued expenses and other	1,000	9,000
Unearned revenue	(18,000)	29,000
Related party payables	16,000	(40,000)
Net cash used in operating activities	(506,000)	(168,000)
CASH FLOWS FROM INVESTING ACTIVITIES
Net cash used in investing activities	0	0
CASH FLOWS FROM FINANCING ACTIVITIES:
Loans from related party	388,000	265,000
Investment to purchase stock	209,000	0
Payments made on financed insurance	(94,000)	(90,000)
Net cash provided by financing activities	503,000	175,000
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(3,000)	7,000
CASH AND EQUIVALENTS, Beginning of year	13,000	6,000
CASH AND EQUIVALENTS, End of year	10,000	13,000
Cash paid during the period for:
Interest	0	0
Income taxes	0	0
Supplemental Disclosure on Non-Cash Activities
Common stock issued for future services	239,000	290,000
Prepaid expenses	90,000	290,000
Beneficial conversion feature	709,000	137,000
Loans converted to equity	388,000	265,000
Annual directors and officers insurance premium	$ 93,000	$ 86,416

1. SUMMARY OF SIGNIFICANT ACCOU

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Description of Business ® GKG can be burned in 100% biomass power plants to generate electricity; made into pellets that can be burned together with coal to reduce carbon emissions from existing power plants; generate bio methane through anaerobic digestion, and can be used as a feedstock for low carbon liquid biofuels for transportation, biochemicals and bio plastics. Cellulosic ethanol, bio butanol and other liquid cellulosic biofuels, do not use corn or other food sources as feedstock. GKG can also be used as animal feed. GKG and other plants absorb and store carbon dioxide from the atmosphere as they grow. When they are burned, they release the carbon dioxide back into the atmosphere, but it is the same carbon dioxide that was removed from the atmosphere, and so this process is carbon neutral. Small amounts of fossil fuel are used by the farm equipment, transportation of GKG and fertilizer, so that the overall process of growing and burning GKG probably has some net carbon dioxide emissions, but much lower emissions than burning coal or other fossil fuels directly to create the same amount of energy. GKG has been independently tested by customers and been shown to have excellent energy content, high bio methane production, and the cellulosic sugar content needed for biofuels and biochemicals. Going Concern – Basis of Presentation Use of Estimates in the Preparation of the Financial Statements Cash and Cash Equivalents – Accounts Receivable and Allowance for Doubtful Accounts – Income Taxes The Company accounts for uncertainty in income taxes using a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining whether it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount which is more than 50% likely of being realized upon ultimate settlement. An uncertain tax position is considered effectively settled on completion of an examination by a taxing authority if certain other conditions are satisfied. Should the Company incur interest and penalties relating to tax uncertainties, such amounts would be classified as a component of interest expense, net and other income (expense), net, respectively. Revenue Recognition With regard to revenue recognition in connection with agreements that include multiple deliverables, management reviews the relevant terms of the agreements and determines whether such deliverables should be accounted for as a single unit of accounting in accordance with FASB ASC 605-25, Multiple-Element Arrangements. If it is determined that the items do not have stand-alone value, then such deliverables are accounted for as a single unit of accounting and any payments received pursuant to such agreement, including any upfront or development milestone payments and any payments received for support services, will be deferred and included in deferred revenue within our balance sheet until such time as management can estimate when all of such deliverables will be delivered, if ever. Management reviews and reevaluates such conclusions as each item in the arrangement is delivered and circumstances of the development arrangement change. Major Customers Stock Based Compensation – Fair Value of Financial Instruments – Under the provisions of the Accounting Standards Codification (“ASC”) 820, Fair Value Measurements and Disclosures (“ASC 820”), there are three levels of inputs that may be used to measure fair value: Level 1. Quoted prices in active markets for identical assets or liabilities. The Company had no Level 1 assets or liabilities during any period presented. Level 2. Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated with observable market data for substantially the full term of the assets or liabilities. The Company had no Level 2 assets or liabilities during any period presented. Level 3. Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of assets or liabilities. The Company had no Level 3 assets or liabilities during any period presented. The carrying value of cash and cash equivalents, prepaid expenses, trade payables and accrued expenses, payables to related parties and deferred revenue approximates fair value due to the short period of time to maturity. Net Income (Loss) Per Share Research and Development Joint Venture ® Recent Accounting Standards – In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entities Ability to Continue as a Going Concern (ASU 2014-15). The guidance in ASU 2014-15 sets forth management's responsibility to evaluate whether there is substantial doubt about an entity's ability to continue as a going concern as well as required disclosures. ASU 2014-15 indicates that, when preparing financial statements for interim and annual financial statements, management should evaluate whether conditions or events, in the aggregate, raise substantial doubt about the entity's ability to continue as a going concern for one year from the date the financial statements are issued or are available to be issued. This evaluation should include consideration of conditions and events that are either known or are reasonably knowable at the date the financial statements are issued or are available to be issued, as well as whether it is probable that management's plans to address the substantial doubt will be implemented and, if so, whether it is probable that the plans will alleviate the substantial doubt. ASU 2014-15 is effective for annual periods ending after December 15, 2016, and interim periods and annual periods thereafter. Early application is permitted. The adoption of this guidance is not expected to have a material impact on the Company’s financial statements. Subsequent Events –

2. PREPAID EXPENSES

2. PREPAID EXPENSES	12 Months Ended
	Dec. 31, 2015
Prepaid Expense and Other Assets, Current [Abstract]
PREPAID EXPENSES	The Company has entered into agreements with certain of its consultants and vendors whereby the Company issued registered shares of its common stock under an existing registration statement on Form S-8 as well as unregistered shares of common stock in exchange for services to be provided to the Company. The Company has engaged a third party provider to pay certain expenses of the Company on behalf of the Company. As compensation for the payment of these expenses on behalf of the Company, the Company pays the provider in shares of common stock equivalent to the expense paid plus a fee equal to 15% of the expense paid. In 2015, the Company issued 10,000,000 shares of the Company’s common stock for future services valued at $90,000. As of December 31, 2015 and December 31, 2014, included in prepaid expenses for this third party provider is $3,000 and $182,000, respectively, for shares of stock issued to the provider in excess of amounts paid on the Company’s behalf. For the year ended December 31, 2015 and 2014, the Company recorded $272,000 and $293,000, respectively, of stock related expenses. Other prepaid expenses (non stock related) were $66,000 and $68,000 at December 31, 2015 and December 31, 2014, respectively.

3. INVESTMENT IN ALMADEN ENERGY

3. INVESTMENT IN ALMADEN ENERGY GROUP	12 Months Ended
	Dec. 31, 2015
Equity Method Investments and Joint Ventures [Abstract]
INVESTMENT IN ALMADEN ENERGY GROUP	The investment in Almaden Energy Group, LLC (“AEG”) represents an 18.75% interest in that company’s outstanding member units which became effective April 15, 2015. The Company originally accounted for this investment by the cost method because the member units of that company is unlisted and the criteria for using the equity method of accounting are not satisfied as the Company is not able to exercise significant influence over AEG. However, upon the Company hiring the CEO of AEG as its CEO in July 2015, the Company changed the method of its investment in AEG to the equity method. Dividends are recognized in income when declared and totaled $0 for the year ended December 31, 2015. The carrying value of the investment is $40,000 as of December 31, 2015. We recorded other income of $84,000 in the Company’s Statements of Operation during the second quarter of 2015. The company recorded a loss on investment in AEG of $44,000 in the fourth quarter of 2015 due to a decrease in its fair value. See Note 9 for additional related party transactions with AEG.

4. STOCK OPTIONS, WARRANTS AND

4. STOCK OPTIONS, WARRANTS AND ISSUED STOCK	12 Months Ended
	Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
STOCK OPTIONS, WARRANTS AND ISSUED STOCK	VIASPACE Inc. 2005 and 2015 Stock Incentive Plans On October 20, 2005, the BOD of the Company adopted the 2005 Stock Incentive Plan (the “Plan”) including the 2005 Non-Employee Director Option Program (the “2005 Director Plan”). The Plan is designed to provide additional incentive to employees, directors and consultants of the Company through awarding incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock and other awards. The Plan was also approved by the holders of a majority of the Company’s common stock. The Plan originally provided for issuance of up to 28,000,000 shares of the Company’s common stock. On February 13, 2006, the BOD approved the 2006 Non-Employee Director Option Program (the “2006 Director Plan”) replacing the 2005 Director Plan and the 2006 Director Plan was approved by the holders of a majority of the Company’s common stock. On July 12, 2006, the Company filed a Form S-8 Registration Statement with the SEC registering 28,000,000 shares of the Company’s common stock. On February 14, 2008, the BOD and the holders of a majority of the Company’s common stock approved an amendment to the Plan which increased the maximum aggregate number of shares which may be issued in the Plan to 99,000,000 shares. On April 30, 2008, the Company filed a Registration Statement on Form S-8 registering 71,000,000 shares of the Company’s common stock. In addition, effective January 1, 2009 and each January 1 thereafter during the term of the Plan, the maximum number of shares under the Plan are to be increased so that the maximum number of shares is equivalent to 30% of the total number of shares of common stock issued and outstanding as of the close of business on the immediately preceding December 31. On February 4, 2009, the Company filed a Registration Statement on Form S-8 registering 146,500,000 shares of the Company’s common stock based on the number of shares of common stock outstanding on December 31, 2008. On August 5, 2015, the BOD of the Company adopted the 2015 Stock Incentive Plan (the “New Plan”) reserving 800,000,000 shares of common stock for issuance. The New Plan is designed to provide additional incentive to employees, directors and consultants of the Company through awarding incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock and other awards. The Plan was also approved by the holders of a majority of the Company’s common stock. The Company has not filed a Form S-8 Registration Statement with the SEC for the New Plan as of December 31, 2015. The Company’s BOD administers the Plan, selects the individuals to whom options will be granted, determines the number of options to be granted, and the term and exercise price of each option. Stock options granted pursuant to the terms of the Plans generally cannot be granted with an exercise price of less than 100% of the fair market value on the grant date. The term of the options granted under the Plan cannot be greater than 10 years. The vesting term is determined by the BOD. The fair value of each stock option granted is estimated on the date of the grant using the Black-Scholes option pricing model. The Black-Scholes option pricing model has assumptions for risk free interest rates, dividends, stock volatility and expected life of an option grant. The risk free interest rate is based upon market yields for United States Treasury debt securities at a maturity near the term remaining on the option. Dividend rates are based on the Company’s dividend history. The stock volatility factor is based on the historical volatility of the Company’s stock price. The expected life of an option grant is based on management’s estimate as no options have been exercised in the Plan to date. The Company calculated a forfeiture rate for employees and directors based on historical information. A forfeiture rate of 0% is used for options granted to employees, directors and consultants. The fair value of each option grant to employees, directors and consultants is calculated by the Black-Scholes method and is recognized as compensation expense on a straight-line basis over the vesting period of each stock option award. For stock options issued to employees, director and consultants for 2015 and 2014, the fair value was estimated at the date of grant using the following range of assumptions: 2015 2014 Risk free interest rate 1.80% - 2.12% 1.97% Dividends 0% 0% Volatility factor 130.65% - 132.00% 132.99% Expected life 6.67 years 6.67 years Annual forfeiture rate 0% 0% The following table summarizes activity for employees and directors in the Company’s Plan and New Plan at December 31, 2015: Number of Shares Weighted- Average Exercise Price Per Share Weighted- Average Remaining Contractual Term In Years Aggregate Intrinsic Value Outstanding at December 31, 2014 97,408,000 $ 0.0120 Granted 165,922,000 0.0039 Exercised – – Cancelled and forfeited 80,100,000 0.0140 Outstanding at December 31, 2015 183,230,000 $ 0.0038 9.40 $ – Exercisable at December 31, 2015 132,874,000 $ 0.0037 9.27 $ – During 2015, stock options totaling 165,922,000 were granted and 80,100,000 stock options were cancelled. At December 31, 2015, there were 715,047,000 shares available for future grant. The Plan recorded $433,000 of compensation expense for employees and director stock options in 2015. At December 31, 2015, there was $156,000 of unrecognized compensation costs related to non-vested share-based compensation arrangements under the Plan that is expected to be recognized over a weighted average period of approximately one year and nine months. At December 31, 2015, the fair value of options vested for employees and directors was $306,000. There were no options exercised during 2015. During 2015, the Company issued 991,009 unregistered shares of common stock to a consultant for services provided to the Company. These share issuances were recorded at $3,840 which is the fair market value determined by the price of the Company’s common stock trading on the OTC Markets on the date of grant.

5. SHORT-TERM AND LONG-TERM DEB

5. SHORT-TERM AND LONG-TERM DEBT	12 Months Ended
	Dec. 31, 2015
Debt Disclosure [Abstract]
SHORT-TERM AND LONG-TERM DEBT	Loan Agreement with Dr. Kevin Schewe Effective September 30, 2012, the Company entered into a Loan Agreement with Director Kevin Schewe whereby Dr. Schewe agreed to loan up to $1 million to the Company over a five-year period based on requests from the Company. The loans would be evidenced by a Secured Convertible Note. Each individual loan will accrue interest at 6% per annum and are secured by all assets of the Company. Each note would mature on the second anniversary of the issuance date of such note. Each note is convertible at Dr. Schewe’s request, into a fixed number of shares of the Company’s common stock based on the closing price of the Company’s common stock for the twenty trading days prior to the issuance of the loan, less a 50% discount. On August 31, 2015, the Board voted to change the discount that Dr. Schewe will receive on conversions of loans into common stock from a discount of 50% to a discount of 80%. In connection with the separation from VGE, Dr. Schewe was granted an irrevocable proxy that permits him to vote the Preferred Share, giving him the majority shareholder vote. As the controlling shareholder of the Company he has the ability to increase the number of authorized shares without additional shareholder approval. As such, if the outstanding balance on the loan was convertible into more shares than the Company has authorized, he has the ability to increase the authorized shares. As a result, the conversion feature is not deemed to be a derivative instrument subject to bifurcation. Schewe completed the funding of $1,000,000 on January 13, 2016. On January 25, 2016, Schewe entered into a new Loan Agreement whereby he agreed to fund the Company an additional $300,000 over a one year period. From January 1, 2015 through December 31, 2015, Dr. Schewe made loans of $388,000 to the Company. The Company recorded a discount on the loans of $709,000 as a result of a beneficial conversion feature, which will be amortized over the term of the note on a straight-line basis, which approximates the effective interest method. During 2015, Dr. Schewe converted loans totaling $388,000 into 321,767,290 common shares of the Company. At the time of the conversions, the company recorded the discount as additional interest expense. As of December 31, 2015, the Company had remaining availability under the note of $5,000.

6. SHAREHOLDERS' DEFICIT

6. SHAREHOLDERS' DEFICIT	12 Months Ended
	Dec. 31, 2015
Equity [Abstract]
SHAREHOLDERS' DEFICIT	Preferred Stock At December 31, 2015 and 2014, the number of authorized shares of the Company’s preferred stock was 10,000,000. The par value of the preferred stock is $0.001. On December 8, 2015, the Company’s board of directors and a majority of its common shareholders approved a resolution to decrease the par value of the Company’s preferred stock from $0.001 to $0.0001. On May 14, 2010, the Company filed with the Secretary of State of the State of Nevada a Certificate of Designation of Series A Preferred Stock. The Certificate was approved by the Board and did not require shareholder vote. The Certificate created a new class of preferred stock known as Series A Preferred Stock. There is one share designated as Series A Preferred Stock. One share of Series A Preferred Stock is entitled to 50.1% of the outstanding votes on all shareholder voting matters. Series A Preferred Stock has no dividend rights and no rights upon a liquidation event and is subject to cancellation when certain conditions are met. On May 14, 2010, the Company issued one share of Series A Preferred Stock to Mr. Chang related to the acquisition of IPA by VIASPACE and VGE, effectively giving him a controlling interest in VIASPACE. Effective as of September 30, 2012, and pursuant to an Agreement to Grant Voting Rights and Transfer Preferred Share executed by Chang and Director Kevin Schewe, Chang granted Schewe an irrevocable proxy that permitted Schewe to vote the Preferred Share. This proxy lasts so long as the License (discussed in Note 10) remained exclusive to the Company. Upon the earlier of (i) the expiration of five years or (ii) the date when the Company reached a market capitalization of at least $50 million, the proxy would be cancelled as the Preferred Share would be transferred from Chang to Schewe. At December 31, 2015 and December 31, 2014, there is one share of Series A Preferred Stock outstanding. Common Stock As of January 1, 2015, the number of authorized shares of the Company’s common stock was 1,800,000,000. On August 7, 2015, the Company’s board of directors and a majority of its common shareholders approved a resolution to increase authorized common shares from 1,800,000,000 shares to 3,900,000,000 shares. As of January 1, 2015, the par value of common and preferred shares was $0.001. On December 8, 2015, the Company’s board of directors and a majority of its common shareholders approved a resolution to decrease the par value of the Company’s common stock from $0.001 to $0.0001. Common shareholders are entitled to one vote for each share held on all matters voted on by shareholders. During 2015, the Company issued 10,991,009 unregistered shares of common stock to employees, consultants and vendors for services provided or to be provided to the Company. These share issuances were recorded at $94,000 which is the fair market value determined by the price of the Company’s common stock trading on the OTC Markets on the date of grant. On April 14, 2015, the Company entered into separate Subscription Agreements with Mr. Haris Basit and Mr. Asad Cochinwala in which each party agreed to purchase 14,285,714 shares of common stock at a purchase price of $0.0035 per share for $50,000. The purchase price per share was equal to 50% of the average closing price of the Company's common stock for the 20 trading days immediately preceeding the date of the investment. The Company received $50,000 from Mr. Basit and $50,000 from Mr. Cochinwala on April 14, 2015. Mr. Basit became CEO and director of the Company on July 10, 2015. Mr Basit is also the CEO of Almaden Energy Group (“AEG”), a customer of the Company as discussed in Note 8. Mr. Cochinwala is CFO of AEG. On July 31, 2015, the Company entered into a Subscription Agreement with a private investor to purchase 14,705,882 shares of common stock at a purchase price of $0.0017 per share for $25,000. The purchase price per share was equal to 50% of the average closing price of the Company's common stock for the 20 trading days immediately preceeding the date of the investment. On August 20, 2015, the Company entered into a Subscription Agreement with a private investor to purchase 13,888,889 shares of common stock at a purchase price of $0.0018 per share for $25,000. The purchase price per share was equal to 50% of the average closing price of the Company's common stock for the 20 trading days immediately preceeding the date of the investment. On October 6, 2015, the Company entered into a Subscription Agreement with a private investor to purchase 23,809,524 shares of common stock at a purchase price of $0.0021 per share for $50,000. The purchase price per share was equal to 50% of the average closing price of the Company's common stock for the 20 trading days immediately preceeding the date of the investment. On November 9, 2015, the Company entered into a Subscription Agreement with Dr. Kukkonen, CTO of the Company, to purchase 4,285,714 shares of common stock at a purchase price of $0.0007 per share for $3,000. The purchase price per share was equal to 20% of the average closing price of the Company's common stock for the 20 trading days immediately preceeding the date of the investment. On December 22, 2015, the Company entered into a Subscription Agreement with Dr. Kukkonen, CTO of the Company, to purchase 15,000,000 shares of common stock at a purchase price of $0.0004 per share for $6,000. The purchase price per share was equal to 20% of the average closing price of the Company's common stock for the 20 trading days immediately preceeding the date of the investment. During 2015, the Company issued 321,767,290 shares of common stock to Director Kevin Schewe as he converted loans into shares of common stock as allowed under an agreement he has with the Company as discussed in Note 5. As of December 31, 2015, there were 1,995,451,343 shares of common stock outstanding.

7. INCOME TAX

7. INCOME TAX	12 Months Ended
	Dec. 31, 2015
Income Tax Disclosure [Abstract]
INCOME TAX	The Company recorded valuation allowances to fully reserve its deferred tax assets, as management believes it is more likely than not that these assets will not be realized. The valuation allowance increased by approximately $260,000 for the year ended December 31, 2014 and increased by $694,000 for the year ended December 31, 2015. It is possible that management’s estimates as to the likelihood of realization of its deferred tax assets could change as a result of changes in estimated operating results. Should management conclude that it is more likely than not that these deferred tax assets are, at least in part, realizable, the valuation allowance will be reduced and recognized as a deferred income tax benefit in the statement of operations in the period of change. The Company has Federal net operating loss carryovers of approximately $20,815,000 available at December 31, 2015 and State net operating loss carryovers of approximately $20,713,000 available at December 31, 2015. The federal and California net operating losses will begin to expire in 2023 and 2015, respectively. Additionally, the Company has capital loss carryforwards of approximately $13,231,000 available at December 31, 2015, which expire through 2018. Due to the uncertainty surrounding the realization of the capital loss carryforwards in future tax returns, the tax effect of the capital loss carryforwards is not recognized in the income tax provision. FASB ASC 740 also addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under ASC 740, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. ASC 740 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. During the years ended December 31, 2015 and 2014, the Company did not recognize any tax liabilities related to uncertain tax positions and does not have a balance for such liabilities as of December 31, 2015. The Company recognizes accrued interest and penalties, if any, associated with uncertain tax positions as part of the income tax provision. There was no accrued interest or penalties associated with uncertain tax positions recognized in the Company’s balance sheets as of December 31, 2015 and 2014. The Company is subject to income tax in the United States federal jurisdiction and various state jurisdictions and has identified its federal tax return and tax returns in state jurisdictions below as “major” tax filings. These jurisdictions, along with the years still open to audit under the applicable statutes of limitation, are as follows: Jurisdiction Tax Years Federal 2012 – 2014 California 2011 – 2014 The following table reconciles the US statutory rates to the Company’s effective tax rate for 2015 and 2014: 2015 2014 U.S Statutory rates 34.0% 34.0% State taxes, net of Federal benefit 5.6% 5.6% Permanent differences (1.0% ) (1.2% ) Change in Valuation allowance (38.6% ) (38.4% ) Other – – Effective income tax rate 0.0% 0.0% The following are the components of the Company’s deferred tax assets and liabilities at December 31, 2015 and 2014: 2015 2014 Deferred Tax Assets: Net operating loss carryforwards $ 8,285,000 $ 7,746,000 Stock compensation expense 4,166,000 4,015,000 Other 4,000 - Total Deferred Tax Assets 12,455,000 11,761,000 Less: Valuation allowance (12,455,000 ) (11,761,000 ) Net Deferred Tax Assets $ – $ –

8. NET LOSS PER SHARE

8. NET LOSS PER SHARE	12 Months Ended
	Dec. 31, 2015
Earnings Per Share [Abstract]
NET LOSS PER SHARE	The Company computes net loss per share in accordance with FASB ASC Topic 260. Under its provisions, basic loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the periods presented. Diluted earnings would customarily include, if dilutive, potential shares of common stock issuable upon the exercise of stock options and warrants. The dilutive effect of outstanding stock options and warrants is reflected in earnings per share in accordance with FASB ASC Topic 260 by application of the treasury stock method. For the periods presented, the computation of diluted loss per share equaled basic loss per share as the inclusion of any dilutive instruments would have had an antidilutive effect on the earnings per share calculation in the periods presented. The following table sets forth common stock equivalents (potential common stock) at December 31, 2015 and 2014 that are not included in the loss per share calculation since their effect would be anti-dilutive for the periods indicated: 2015 2014 Stock Options 183,230,000 97,408,000 The following table sets forth the computation of basic and diluted net loss per share for 2015 and 2014, respectively: 2015 2014 Basic and diluted net loss per share: Numerator: Net loss attributable to common stock $ (2,006,000 ) $ (752,000 ) Denominator: Weighted average shares of common stock outstanding 1,704,277,945 1,520,187,700 Net loss per share of common stock, basic and diluted $ * $ * __________ * Less than $0.01

9. RELATED PARTY TRANSACTIONS

9. RELATED PARTY TRANSACTIONS	12 Months Ended
	Dec. 31, 2015
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	Included in the Company’s balance sheets at December 31, 2015 and December 31, 2014 are Related Party Payables of $656,000 and $640,000, respectively. The Company has a payable of $640,000, at December 31, 2015 and December 31, 2014 owed to Dr. Carl Kukkonen. On July 10, 2015, Dr. Kukkonen’s title changed from CEO to Chief Technology Office (“CTO”) after the Company hired Mr. Haris Basit to be the CEO of the Company. Of the amount owed to Dr. Kukkonen, there is a cash component totaling $136,000 and a common stock component totaling $504,000. Dr. Kukkonen deferred a portion of his 2009, 2010 and 2011 stock awards and is entitled to the following unregistered shares of Company common stock at December 31, 2015: 11,195,707 shares for deferred 2009 compensation; 8,467,939 shares for deferred 2010 compensation; and 24,730,678 shares for deferred 2011 compensation. At December 31, 2015, the Company also has a royalty payable to VGE of $16,000. There was no corresponding payable to VGE at December 31, 2014. The Company has a loan agreement with Director Dr. Kevin Schewe which is described in Note 5. On December 18, 2013, the Company entered into a Representation in Pakistan and Giant King Grass supply contract with Winergy Pakistan Private Limited (“Winergy”), a company incorporated and existing under the laws of Pakistan. Mr. Khurram Irshad, a director of the Company, is a director and shareholder of Winergy. Winergy was also appointed the exclusive representative of the Company in Pakistan. Winergy is developing bioenergy and animal feed projects in Pakistan and seeking a biomass source. The Company's Giant King Grass will be supplied to Winergy and a propagation nursery and test plot is to be established in Pakistan. Winergy will operate and pay the expenses for a Giant King Grass propagation nursery and test plot in Pakistan. Winergy paid a one-time fee of $5,000 to the Company upon the signing of the contract. The Company expects to receive additional license fees in the future from Winergy when they are able to secure relationships with customers who will use the Company's Giant King Grass in their particular application. No revenues were received from Winergy in 2015. On April 13, 2015, the Company entered into a Giant King Grass supply contract with Almaden Energy Group, LLC. (“AEG”). AEG is developing an animal feed project in the United States for the domestic and global market. The Company granted AEG a license to grow Giant King Grass only for animal feed, nursery and research purposes anywhere within the 48 contiguous United States. AEG is permitted to sell Giant King Grass anywhere in the world with the exception of the State of Hawaii. AEG will provide funding to the Company in return for the Company providing seedlings and technical support and training to establish the initial 25 acres plantation in Imperial County, CA. Twenty-six acres were leased of which 20 acres were planted in August 2015. Additional acres will be planted in spring of 2016. As part of the supply contract, the Company was issued 25% equity ownership in AEG and one designated board seat provided that the Company maintains an equity ownership position greater than 5%. As part of the Company’s agreement with director Khurram Irshad, the Company is required to issue 25% of its equity ownership interest in AEG to Mr. Irshad. At December 31, 2015, the Company recorded $40,000 as an Investment in AEG on its Balance Sheet representing the fair value estimate of the Company’s minority interest in AEG (see Note 3). As discussed in Note 6, on April 14, 2015, two principals of AEG invested $100,000 to purchase unregistered shares of the Company’s common stock. One of these investors, Mr. Haris Basit, became CEO and director of the Company on July 10, 2015 and is also the CEO of AEG. The other investor was Asad Cochinwala who is CFO of AEG. In total, 28,571,428 common shares of the Company are owned by the founding partners of AEG, Mr. Basit and Mr. Cochinwala. Additionally, as discussed in Note 6, the Company entered into a Subscription Agreement with Dr. Kukkonen, CTO of the Company, to purchase 4,285,714 shares of common stock at a purchase price of $0.0007 per share for $3,000.

10. COMMITMENTS AND CONTINGENCI

10. COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	Leases The Company currently has no long term office lease. The Company leases land in San Diego County, California where it grows Giant King Grass. Rent expense charged to operations for the year ended December 31, 2015 and December 31, 2014, was $12,000 and $16,000, respectively. Collaborative Agreements We are a party to certain collaborative agreements with various entities for the joint operation of test plots to establish that GKG grows well in the area and optimal agronomic practices are developed. These agreements are in the form of development collaborations and licensing agreements. Under these agreements, we have granted rights to grow and use of GKG. In return, we are entitled to receive certain payments for the operations of the test plots and license fees on the harvesting of GKG should it ultimately be commercialized. All of our collaborative agreements are subject to termination by either party, without significant financial penalty. Under the terms of these agreements, upon a termination we are entitled to reacquire all rights in our technology at no cost and are free to re-license the technology to other collaborative partners. Revenue earned from collaborative agreements is comprised of negotiated payments for the establishment, evaluation and operations of GKG test plots. Deferred revenue represents customer payments received which are related to future performance. Generally for collaborative agreements establishing test plots, the Company recognizes revenue only after the Giant King Grass is planted in the customer’s location. Until that time any money received is recorded as deferred revenue. During the years ending December 31, 2015 and 2014, the Company received $129,000 and $182,000, respectively, in payments under these collaborative agreements. The Company recognized revenue from these collaborative agreements of $188,000 and $153,000 for the years ending December 31, 2015 and 2014, respectively. License Agreement Effective as of September 30, 2012, VIASPACE and VGE entered into a Supply, License and Commercialization Agreement (“License Agreement”) pursuant to which VGE granted to VIASPACE a nontransferable, royalty-bearing exclusive license to commercialize Giant King Grass anywhere within the world other than China and Taiwan. Additionally, the License Agreement allows VIASPACE to use the Giant King Grass intellectual property and VIASPACE Green Energy trade name in connection with its efforts to commercialize Giant King Grass. The Company assigned no value to the sublicense due to uncertainties of future revenues. VIASPACE agreed that it would not during the term of the License Agreement and a three-year period thereafter, (i) manufacture, commercialize or otherwise engage in any research or development of a grass or any other product or material having similar or otherwise competitive properties to Giant King Grass. VGE agreed to provide VIASPACE with Giant King Grass seedlings that will be filled at an agreed upon price as set forth in the License Agreement. VIASPACE agreed to pay VGE for and during the Term a royalty of eight percent (8%) on net sales made in its territory. The initial term of the License Agreement is for two years (“Initial Term”). As a condition to the right to renew after the first two-year term for an additional two year term, VIASPACE needed to achieve the milestones in the first two year period: · One or more fully-executed, third party sales contracts for the sale of Giant King Grass shall have been entered into during the Initial Term, pursuant to which VIASPACE is to be paid an aggregate amount of at least $200,000 within that 24 consecutive monthly period; and two or more, third party growing locations of at least 10 hectares in total shall have been obtained and planted during the Initial Term. The Company has entered into various collaborative agreements with entities for the joint operation of test plots to satisfy these milestones. These milestones were achieved by the Company as of September 30, 2014 and the license was renewed for another two years. As a condition to the right to renew the First Renewal Term (for years five and six) of the License Agreement, the Company is to achieve during the First Renewal Term the following milestones by September 30, 2016 as a condition to any such renewal: · A total of least three or more (including the above) fully-executed, third party sales contracts for the sale of Giant King Grass shall have been entered into during the First Renewal Term, pursuant to which the Registrant is to be paid the aggregate amount of $400,000, with not less than $100,000 of the Initial Sales Milestone having been paid during the First Renewal Term and with the remaining unpaid balance of the Initial Sales Milestone being paid within six months of the Second Renewal Term (e.g., in the fifth year) and the Second Sales Milestone being paid in full within that 24 consecutive monthly period following the signing of any such third contract; and · A total of at least three or more (including the two above) growing locations of at least 30 hectares in total shall have been obtained and planted during the Second Renewal Term, which shall be subject to the reasonable satisfaction of VGE. Employment Agreements Effective July 10, 2015, the Company entered into a two-year employment agreement with Haris Basit, CEO of the Company. Mr. Basit will receive $120,000 per annum and be entitled to a bonus as determined by the Company’s Board of Directors and reimbursement for out-of-pocket expenses in the course of his employment. Additionally, Mr. Basit is to receive 20 business days paid leave per year. On July 10, 2015, the Company agreed to issue Mr. Basit 25,000,000 stock options at fair market value based on the closing price of the Company’s common stock as traded on the OTC Market as of July 10, 2015. These stock options are vested immediately but otherwise shall be subject to the terms of the 2015 option plan. Additionally, the Company agreed to issue Mr. Basit 18,750,000 stock options to be issued every three months (quarterly) over the term of his employment agreement which runs from July 10, 2015 through July 9, 2017, with the first issuance on October 10, 2015, at fair market value based on the closing price of the Company’s common stock as traded on the OTC Market on the date of each grant. Stock options shall vest immediately upon each issuance and shall be otherwise subject to the terms of the 2015 option plan. In the case of a change of control of the Company, the issuance schedule shall be accelerated by one year. Stock options shall have an exercise term of ten years from date of issuance, not to exceed the expiration date of the 2015 option plan. Effective October 1, 2015, the Company entered into one-year employment agreements with Carl Kukkonen and Stephen Muzi. Dr. Kukkonen serves as Chief Technology Officer of the Company and Mr. Muzi serves as Chief Financial Officer, Treasurer and Secretary. Dr. Kukkonen will receive a salary of $120,000 per annum and Mr. Muzi would receive $64,000 per annum. Each of them would also be entitled to customary insurance and health benefits, and reimbursement for out-of-pocket expenses in the course of his employment. Dr. Kukkonen is to receive 20 business days paid leave per year and Mr. Muzi is to receive 10 business days paid leave. Additionally, Dr. Kukkonen will be awarded a bonus of 10% of the gross revenue generated by the Company up to a maximum of $100,000. Dr. Kukkonen will also be purchasing $3,000 per month worth of Company unregistered common shares at a price equal to 20% of the average closing price of the Company's common stock for the 20 trading days immediately preceeding the purchase date. Litigation The Company is not party to any material legal proceedings at the present time.

11. SUBSEQUENT EVENTS

11. SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2015
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	On January 13, 2016, Dr. Kevin Schewe, Director of the Company, advanced an additional $5,000 pursuant to the convertible loan agreement and immediately converted the $5,000 loan into 12,500,000 shares of Company common stock at a conversion price of $0.0004 per common share. On January 25, 2016, Schewe entered into a new convertible loan Agreement whereby he agreed to fund the Company an additional $300,000 over a one year period. The loans would be evidenced by a secured convertible note. The notes accrue interest at 8% per annum, and are secured by all assets of the Company pursuant to a security agreement and are convertible into shares of Company common stock at a price equal to 20% of the average closing price for the 20 trading days prior to the issuance of the loan. On January 27, 2016, Dr. Kevin Schewe, Director of the Company, advanced an additional $15,000 pursuant to the convertible loan agreement and immediately converted the $15,000 loan into 37,500,000 shares of Company common stock at a conversion price of $0.0004 per common share. On February 25, 2016, the Company entered into a Subscription Agreement with Almaden Energy Group, LLC. ("AEG"), a related party whose CEO is Haris Basit, CEO of the Company, in which AEG agreed to purchase 12,500,000 shares of common stock at a purchase price of $0.0016 per share for $20,000. The purchase price per share was equal to 50% of the average closing price of the Registrant's common stock for the 20 trading days immediately preceeding the date of the investment. Additionally, AEG and the Company signed an Addendum which amended the April 13, 2015 Grass Supply Contract (the "Contract) for Giant King Grass. $30,000 was still owed to the Company for the Contract by AEG. AEG agreed to pay $20,000 of the $30,000 owed to the Registrant, but in return would received Company common shares with a market value of $40,000 (i.e. 50% discount to current market price). $10,000 remains to be paid to Company by AEG at a later date. On February 26, 2016, Dr. Kevin Schewe, Director of the Company, advanced an additional $15,000 pursuant to the convertible loan agreement and immediately converted the $15,000 loan into 25,000,000 shares of Company common stock at a conversion price of $0.0006 per common share. On February 26, 2016, the Company entered into a Subscription Agreement with Dr. Carl Kukkonen, Chief Technology Officer of the Company, to purchase 5,000,000 shares of common stock at a purchase price of $0.0006 per share for $3,000. The purchase price per share was equal to 20% of the average closing price of the Company's common stock for the 20 trading days immediately preceding the date of the investment. On March 28, 2016, Dr. Kevin Schewe, Director of the Company, advanced an additional $15,000 pursuant to the convertible loan agreement and immediately converted the $15,000 loan into 25,000,000 shares of Company common stock at a conversion price of $0.0006 per common share. On March 28, 2016, the Company entered into a Subscription Agreement with Dr. Carl Kukkonen, Chief Technology Officer of the Company, to purchase 5,000,000 shares of common stock at a purchase price of $0.0006 per share for $3,000. The purchase price per share was equal to 20% of the average closing price of the Company's common stock for the 20 trading days immediately preceding the date of the investment.

1. SUMMARY OF SIGNIFICANT ACC18

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Description of Business	Description of Business ® GKG can be burned in 100% biomass power plants to generate electricity; made into pellets that can be burned together with coal to reduce carbon emissions from existing power plants; generate bio methane through anaerobic digestion, and can be used as a feedstock for low carbon liquid biofuels for transportation, biochemicals and bio plastics. Cellulosic ethanol, bio butanol and other liquid cellulosic biofuels, do not use corn or other food sources as feedstock. GKG can also be used as animal feed. GKG and other plants absorb and store carbon dioxide from the atmosphere as they grow. When they are burned, they release the carbon dioxide back into the atmosphere, but it is the same carbon dioxide that was removed from the atmosphere, and so this process is carbon neutral. Small amounts of fossil fuel are used by the farm equipment, transportation of GKG and fertilizer, so that the overall process of growing and burning GKG probably has some net carbon dioxide emissions, but much lower emissions than burning coal or other fossil fuels directly to create the same amount of energy. GKG has been independently tested by customers and been shown to have excellent energy content, high bio methane production, and the cellulosic sugar content needed for biofuels and biochemicals.
Going Concern	Going Concern –
Basis of Presentation	Basis of Presentation
Use of Estimates in the Preparation of the Financial Statements	Use of Estimates in the Preparation of the Financial Statements
Cash and cash equivalents	Cash and Cash Equivalents –
Accounts Receivable and Allowance for Doubtful Accounts	Accounts Receivable and Allowance for Doubtful Accounts –
Income Taxes	Income Taxes The Company accounts for uncertainty in income taxes using a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining whether it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount which is more than 50% likely of being realized upon ultimate settlement. An uncertain tax position is considered effectively settled on completion of an examination by a taxing authority if certain other conditions are satisfied. Should the Company incur interest and penalties relating to tax uncertainties, such amounts would be classified as a component of interest expense, net and other income (expense), net, respectively.
Revenue Recognition	Revenue Recognition With regard to revenue recognition in connection with agreements that include multiple deliverables, management reviews the relevant terms of the agreements and determines whether such deliverables should be accounted for as a single unit of accounting in accordance with FASB ASC 605-25, Multiple-Element Arrangements. If it is determined that the items do not have stand-alone value, then such deliverables are accounted for as a single unit of accounting and any payments received pursuant to such agreement, including any upfront or development milestone payments and any payments received for support services, will be deferred and included in deferred revenue within our balance sheet until such time as management can estimate when all of such deliverables will be delivered, if ever. Management reviews and reevaluates such conclusions as each item in the arrangement is delivered and circumstances of the development arrangement change.
Major Customers	Major Customers
Stock Based Compensation	Stock Based Compensation –
Fair Value of Financial Instruments	Fair Value of Financial Instruments – Under the provisions of the Accounting Standards Codification (“ASC”) 820, Fair Value Measurements and Disclosures (“ASC 820”), there are three levels of inputs that may be used to measure fair value: Level 1. Quoted prices in active markets for identical assets or liabilities. The Company had no Level 1 assets or liabilities during any period presented. Level 2. Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated with observable market data for substantially the full term of the assets or liabilities. The Company had no Level 2 assets or liabilities during any period presented. Level 3. Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of assets or liabilities. The Company had no Level 3 assets or liabilities during any period presented. The carrying value of cash and cash equivalents, prepaid expenses, trade payables and accrued expenses, payables to related parties and deferred revenue approximates fair value due to the short period of time to maturity.
Net Income (Loss) Per Share	Net Income (Loss) Per Share
Research and Development	Research and Development
Joint Venture	Joint Venture ®
Recent Accounting Standards	Recent Accounting Standards – In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entities Ability to Continue as a Going Concern (ASU 2014-15). The guidance in ASU 2014-15 sets forth management's responsibility to evaluate whether there is substantial doubt about an entity's ability to continue as a going concern as well as required disclosures. ASU 2014-15 indicates that, when preparing financial statements for interim and annual financial statements, management should evaluate whether conditions or events, in the aggregate, raise substantial doubt about the entity's ability to continue as a going concern for one year from the date the financial statements are issued or are available to be issued. This evaluation should include consideration of conditions and events that are either known or are reasonably knowable at the date the financial statements are issued or are available to be issued, as well as whether it is probable that management's plans to address the substantial doubt will be implemented and, if so, whether it is probable that the plans will alleviate the substantial doubt. ASU 2014-15 is effective for annual periods ending after December 15, 2016, and interim periods and annual periods thereafter. Early application is permitted. The adoption of this guidance is not expected to have a material impact on the Company’s financial statements.
Subsequent Events	Subsequent Events –

4. STOCK OPTIONS, WARRANTS AN19

4. STOCK OPTIONS, WARRANTS AND ISSUED STOCKS (Tables)	12 Months Ended
	Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Fair value assumptions	2015 2014 Risk free interest rate 1.80% - 2.12% 1.97% Dividends 0% 0% Volatility factor 130.65% - 132.00% 132.99% Expected life 6.67 years 6.67 years Annual forfeiture rate 0% 0%
Employee and Director Option Grants	Number of Shares Weighted- Average Exercise Price Per Share Weighted- Average Remaining Contractual Term In Years Aggregate Intrinsic Value Outstanding at December 31, 2014 97,408,000 $ 0.0120 Granted 165,922,000 0.0039 Exercised – – Cancelled and forfeited 80,100,000 0.0140 Outstanding at December 31, 2015 183,230,000 $ 0.0038 9.40 $ – Exercisable at December 31, 2015 132,874,000 $ 0.0037 9.27 $ –

7. INCOME TAX (Tables)

7. INCOME TAX (Tables)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Jurisdiction with Years	Jurisdiction Tax Years Federal 2012 – 2014 California 2011 – 2014
US statutory rates	2015 2014 U.S Statutory rates 34.0% 34.0% State taxes, net of Federal benefit 5.6% 5.6% Permanent differences (1.0% ) (1.2% ) Change in Valuation allowance (38.6% ) (38.4% ) Other – – Effective income tax rate 0.0% 0.0%
Deferred tax assets and liabilities	2015 2014 Deferred Tax Assets: Net operating loss carryforwards $ 8,285,000 $ 7,746,000 Stock compensation expense 4,166,000 4,015,000 Other 4,000 - Total Deferred Tax Assets 12,455,000 11,761,000 Less: Valuation allowance (12,455,000 ) (11,761,000 ) Net Deferred Tax Assets $ – $ –

8. NET LOSS PER SHARE (Tables)

8. NET LOSS PER SHARE (Tables)	12 Months Ended
	Dec. 31, 2015
Earnings Per Share [Abstract]
Common Stock Equivalents Not Included in Loss per Share	2015 2014 Stock Options 183,230,000 97,408,000
Computation of basic and diluted net loss per share	2015 2014 Basic and diluted net loss per share: Numerator: Net loss attributable to common stock $ (2,006,000 ) $ (752,000 ) Denominator: Weighted average shares of common stock outstanding 1,704,277,945 1,520,187,700 Net loss per share of common stock, basic and diluted $ * $ *

1. SUMMARY OF SIGNIFICANT ACC22

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Accumulated deficit	$ (52,247,000)	$ (50,241,000)
Cash equivalents	0	0
Research and development	0	0
Equity method investment	40,000	$ 0
Corporacion Agricola [Member]
Equity method investment	$ 0
Sales Revenue, Net [Member] | Five Customers [Member]
Concentration risk percentage	100.00%

2. PREPAID EXPENSES (Details Na

2. PREPAID EXPENSES (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Prepaid expenses	$ 69,000	$ 250,000
Stock related expenses	$ 272,000	293,000
Stock issued for payment of prepaid expenses, shares issued	10,000,000
Stock issued for payment of prepaid expenses, value	$ 90,000
Prepaid Expenses [Member] | Share value in excess of amounts paid [Member]
Prepaid expenses	3,000	182,000
Prepaid Expenses [Member] | Non-Stock Related Expenses [Member]
Prepaid expenses	$ 66,000	$ 68,000

3. INVESTMENT IN ALMADEN ENER24

3. INVESTMENT IN ALMADEN ENERGY GROUP (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2015	Dec. 31, 2014
Investment		$ 40,000	$ 0
Other income		84,000	5,000
Loss on investment in AEG		$ (44,000)	$ 0
Almaden Energy Group [Member]
Equity investment percentage		18.75%
Dividends from equity investment	$ 0	$ 0
Investment		40,000
Other income		84,000
Loss on investment in AEG		$ (44,000)

4. STOCK OPTIONS, WARRANTS AN25

4. STOCK OPTIONS, WARRANTS AND ISSUED STOCKS (Details - Assumptions)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Risk free interest rate, minimum	1.80%	1.97%
Risk free interest rate, maximum	2.12%	1.97%
Dividends	0.00%	0.00%
Volatility factor, minimum	130.65%	132.99%
Volatility factor, maximum	132.00%	132.99%
Expected life	6 years 8 months 1 day	6 years 8 months 1 day
Annual forfeiture rate	0%	0%

4. STOCK OPTIONS, WARRANTS AN26

4. STOCK OPTIONS, WARRANTS AND ISSUED STOCK (Details-Option activity)	12 Months Ended
	Dec. 31, 2015USD ($)$ / sharesshares
Number of Shares
Outstanding, beginning balance	97,408,000
Granted	165,922,000
Exercised	0
Cancelled and forfeited	80,100,000
Outstanding, ending balance	183,230,000
Exercisable, ending balance	132,874,000
Weighted Average Exercise Price Per Share
Outstanding, beginning balance | $ / shares	$ .0120
Weighted average exercise price, granted | $ / shares	.0039
Weighted average exercise price, cancelled and forfeited | $ / shares	.0140
Outstanding, ending balance | $ / shares	.0038
Exercisable, ending balance | $ / shares	$ .0037
Weighted Average Remaining Contractual Terms in Years
Outstanding, ending balance	9 years 4 months 24 days
Exercisable, ending balance	9 years 3 months 7 days
Aggregate Intrinsic Value
Outstanding, ending balance | $	$ 0
Exercisable, ending balance | $	$ 0

4. STOCK OPTIONS, WARRANTS AN27

4. STOCK OPTIONS, WARRANTS AND ISSUED STOCK (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Options available for future grant	715,047,000
Unrecognized compensation costs related to non-vested shares	$ 156,000
Weighted average period of unrecognized compensation costs	1 year 9 months
Fair value of options vested	$ 306,000
Options exercised	0
Stock compensation expense	$ 463,000	$ 61,000
Stock issued for services, value	$ 94,000	$ 293,000
Consultant [Member]
Stock issued for services, shares	991,009
Stock issued for services, value	$ 3,840

5. SHORT-TERM AND LONG-TERM D28

5. SHORT-TERM AND LONG-TERM DEBT (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Proceeds from note payable	$ 388,000	$ 265,000
Schewe [Member]
Proceeds from note payable	388,000
Discount on loans from shareholder	709,000
Loans converted into shares, loan amount converted	$ 388,000
Loans converted into shares, shares issued	321,767,290

6. SHAREHOLDERS' DEFICIT (Detai

6. SHAREHOLDERS' DEFICIT (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Stock issued for services, value	$ 94,000	$ 293,000
Proceeds from subscription agreements	$ 209,000	$ 0
Schewe [Member]
Loans converted into shares, shares issued	321,767,290
Mr. Basit [Member]
Stock to be issued, shares	14,285,714
Proceeds from subscription agreements	$ 50,000
Mr. Cochinwala [Member]
Stock to be issued, shares	14,285,714
Proceeds from subscription agreements	$ 50,000
Employees, Consultants and Vendors [Member]
Stock issued for services, shares	10,991,009
Stock issued for services, value	$ 94,000
Private Investor [Member]
Stock issued for cash, shares issued	14,705,882
Stock issued for cash, value	$ 25,000
Private Investor [Member]
Stock issued for cash, shares issued	13,888,889
Stock issued for cash, value	$ 25,000
Private Investor [Member]
Stock issued for cash, shares issued	23,809,524
Stock issued for cash, value	$ 50,000
Dr. Kukkonen [Member] | November 9, 2015 [Member]
Stock issued for cash, shares issued	4,285,714
Stock issued for cash, value	$ 3,000
Dr. Kukkonen [Member] | December 22, 2015 [Member]
Stock issued for cash, shares issued	15,000,000
Stock issued for cash, value	$ 6,000

7. INCOME TAX (Details-Effectiv

7. INCOME TAX (Details-Effective rate)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Income Tax Disclosure [Abstract]
U.S Statutory rates	34.00%	34.00%
State taxes, net of Federal benefit	5.60%	5.60%
Permanent differences	(1.00%)	(1.20%)
Change in Valuation allowance	(38.60%)	(38.40%)
Other	0.00%	0.00%
Effective income tax rate	0.00%	0.00%

7. INCOME TAX (Details-Deferred

7. INCOME TAX (Details-Deferred tax assets) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Deferred Tax Assets:
Net operating loss carryforwards	$ 8,285,000	$ 7,746,000
Stock compensation expense	4,166,000	4,015,000
Other deferred tax asset	4,000	0
Total Deferred Tax Assets	12,455,000	11,761,000
Less: Valuation allowance	(12,455,000)	(11,761,000)
Net Deferred Tax Assets	$ 0	$ 0

7. INCOME TAX (Details Narrativ

7. INCOME TAX (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Increase in valuation allowance	$ 694,000	$ 260,000
Capital loss carryover		$ 13,231,000
Capital loss expiration date		Dec. 31, 2018
Uncertain tax positions		$ 0
Federal [Member]
Net operating loss carryover		$ 20,815,000
Operating loss expiration date beginning		Dec. 31, 2023
State [Member]
Net operating loss carryover		$ 20,713,000
Operating loss expiration date beginning		Dec. 31, 2015

8. NET LOSS PER SHARE (Details-

8. NET LOSS PER SHARE (Details-Equivalents) - shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Earnings Per Share [Abstract]
Common stock equivalents excluded from EPS	183,230,000	97,408,000

8. NET LOSS PER SHARE (Detail34

8. NET LOSS PER SHARE (Details-EPS) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Basic and diluted net income (loss) per share:
Numerator : Net loss attributable to common stock	$ (2,006,000)	$ (752,000)
Denominator
Weighted average shares of common stock outstanding	1,704,277,945	1,520,187,700
Net loss per share of common stock, basic and diluted	$ 0	$ 0	[1]
[1]	Less than $0.01 per common share

9. RELATED PARTY TRANSACTIONS (

9. RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Related party payables	$ 656,000	$ 640,000
Carl Kukkonen [Member]
Related party payables	640,000	$ 640,000
VGE [Member]
Related party payables	$ 16,000

10. OTHER COMMITMENTS AND CONTI

10. OTHER COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Rent Expense	$ 12,000	$ 16,000
Revenue received from collaborative agreements	129,000	182,000
Revenue recognized from collaborative agreements	$ 188,000	$ 153,000